Blood test may allow safer, Lower-Dose radiation for head and neck cancer

NCT ID NCT05962242

First seen Feb 05, 2026 · Last updated Apr 29, 2026 · Updated 13 times

Summary

This study tests whether a blood test that tracks HPV DNA can help doctors safely give a lower dose of radiation to the neck in people with head and neck cancer. About 90 adults with oropharynx cancer will receive radiation tailored to their blood test results. The goal is to see if this approach can control the cancer while reducing side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bon Secours

    NOT_YET_RECRUITING

    Richmond, Virginia, 23114, United States

    Contact

  • Eastern Virginia Medical School

    NOT_YET_RECRUITING

    Norfolk, Virginia, 23507, United States

    Contact

  • Miami Cancer Institute

    RECRUITING

    Miami, Florida, 33176, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Virginia

    RECRUITING

    Charlottesville, Virginia, 22908, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Virginia Commonwealth University

    RECRUITING

    Richmond, Virginia, 23284, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.